Effects of birth size, post-natal growth and current size on insulin resistance in 9-year-old children: a prospective

Melissa J Whitrow1, Michael J Davies, Lynne C Giles

  • 1Discipline of Obstetrics & Gynaecology, School of Paediatrics & Reproductive Health, The University of Adelaide, Mail Drop 327, Adelaide, SA 5005, Australia. melissa.whitrow@adelaide.edu.au

Insights

Childhood growth impacts insulin resistance (IR). Accelerated growth from birth to age 9, particularly around 3.5 years, may influence later IR risk. Early body size is key for metabolic health.

Area of Science:

  • Pediatrics
  • Metabolic Health
  • Developmental Biology

Background:

  • Prenatal conditions can influence later type 2 diabetes risk factors, including insulin resistance (IR).
  • Postnatal growth trajectory may mediate the effects of prenatal influences on IR.
  • Understanding early growth patterns is crucial for predicting future metabolic health.

Purpose of the Study:

  • To investigate the association between body size at birth and age 9 with insulin resistance (IR) at age 9.
  • To explore the role of postnatal growth trajectory in mediating the relationship between early body size and later IR.
  • To examine potential interactions between birth size and childhood growth on IR development.

Main Methods:

  • Prospective Australian cohort study.
  • Analysis of body size z-scores (weight or BMI) at birth and age 9.
  • Insulin resistance (IR) estimated using homeostasis model assessment (HOMA-IR) at age 9 in 151 children.

Main Results:

  • Higher BMI z-score at age 9 was positively associated with IR.
  • Birth BMI z-score showed an inverse association with IR only after adjusting for age 9 BMI z-score, suggesting accelerated growth's impact.
  • A significant interaction between birth and age 9 BMI z-scores was observed, with potential inverse association between body size at 3.5 years and HOMA-IR at 9 years.

Conclusions:

  • Early life growth, from birth to age 9, is important for later insulin resistance.
  • Accelerated growth between birth and age 9 may influence insulin resistance.
  • The specific growth period around 3.5 years warrants further investigation for its impact on HOMA-IR at age 9.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...